The extraordinary ligand binding properties of human serum albumin

IUBMB Life - Tập 57 Số 12 - Trang 787-796 - 2005

Mauro Fasano¹, Stephen Curry², Enzo Terreno³, Monica Galliano⁴, Gabriella Fanali¹, Pasquale Narciso⁵, Stefania Notari⁵, Paolo Ascenzi⁵

¹Department of Structural and Functional Biology, University of Insubria, and Center of Neurosciences, Busto Arsizio, VA, Italy

²Department of Biological Sciences, Imperial College London, London, UK

³Department of Chemistry IFM, University of Torino, Torino, Italy

⁴Department of Biochemistry 'Alessandro Castellani', Università of Pavia, Pavia, Italy

⁵National Institute for Infectious Diseases IRCCS 'Lazzaro Spallanzani', Roma, Italy

Tóm tắt

Từ khóa

Tài liệu tham khảo

Cistola, D. and Small, D. (1991) Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study J. Clin. Invest, 87, pp. 1431 - 1441.

Spector, A. (1975) Fatty acid binding to plasma albumin J. Lipid Res, 16, pp. 165 - 179.

Kragh-Hansen, U. (1981) Molecular aspects of ligand binding to serum albumin Pharmacol. Rev, 33, pp. 17 - 53.

Carter, D. and Ho, J. (1994) Structure of serum albumin Adv. Protein Chem, 45, pp. 153 - 203.

Curry, S. (2002) Beyond expansion: structural studies on the transport roles of human serum albumin Vox Sang, 83(Suppl. 1), pp. 315 - 319.

Ascenzi, P. and Bocedi, A. and Bolli, A. and Fasano, M. and Notari, S. and Polticelli, F. (2005) Allosteric modulation of monomeric proteins Biochem. Mol. Biol. Educ, 33, pp. 169 - 176.

Sudlow, G. and Birkett, D. and Wade, D. (1975) The characterization of two specific drug binding sites on human serum albumin Mol. Pharmacol, 11, pp. 824 - 832.

Vallner, J. (1977) Binding of drugs by albumin and plasma protein J. Pharm. Sci, 66, pp. 447 - 465.

Aime, S. and Botta, M. and Fasano, M. and Geninatti, S. and Terreno, E. (1996) Gd(III) complexes as contrast agents for magnetic resonance imaging: a proton relaxation enhancement study of the interaction with human serum albumin J. Biol. Inorg. Chem, 1, pp. 312 - 319.

(1996) All about Albumin: Biochemistry, Genetics and Medical Applications. San Diego and London : Academic Press.

Vorum, H. and Honoré, B. (1996) Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy J. Pharm. Pharmacol, 48, pp. 870 - 875.

Aime, S. and Botta, M. and Fasano, M. and Terreno, E. (1998) Lanthanide chelates for NMR biomedical applications Chem. Soc. Rev, 27, pp. 19 - 29.

Aime, S. and Botta, M. and Fasano, M. and Terreno, E.(2001) Protein-bound metal chelates. In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. ( pp. 193 - 242 ). Chichester : John Wiley & Sons. Ch. 5,

Bertucci, C. and Domenici, E. (2002) Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance Curr. Med. Chem, 9, pp. 1463 - 1481.

Kragh-Hansen, U. and Chuang, V. and Otagiri, M. (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol. Pharm. Bull, 25, pp. 695 - 704.

Sułkowska, A. and Bojko, B. and Równicka, J. and Sułkowski, W. (2004) Competition of drugs to serum albumin in combination therapy Biopolymers, 74, pp. 256 - 262.

Carter, D. and Ho, J. and Rüker, F. (1999) Oxygen-transporting albumin-based blood replacement composition and blood volume expander. U.S. Pat. No. 5,948,609

Monzani, E. and Bonafè, B. and Fallarini, A. and Redaelli, C. and Casella, L. and Minchiotti, L. and Galliano, M. (2001) Enzymatic properties of hemalbumin Biochim. Biophys. Acta, 1547, pp. 302 - 312.

Komatsu, T. and Ohmichi, N. and Zunszain, P. and Curry, S. and Tsuchida, E. (2004) Dioxygenation of human serum albumin having a prosthetic heme group in a tailor-made heme pocket J. Am. Chem. Soc, 126, pp. 14304 - 14305.

Sakurai, Y. and Ma, S. and Watanabe, H. and Yamaotsu, N. and Hirono, S. and Kurono, Y. and Kragh-Hansen, U. and Otagiri, M. (2004) Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates Pharm. Res, 21, pp. 285 - 292.

He, X. and Carter, D. (1992) Atomic structure and chemistry of human serum albumin Nature, 358, pp. 209 - 215.

Curry, S. and Mandelkov, H. and Brick, P. and Franks, N. (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nat. Struct. Biol, 5, pp. 827 - 835.

Sugio, S. and Kashima, A. and Mochizuki, S. and Noda, M. and Kobayashi, K. (1999) Crystal structure of human serum albumin at 2.5 Å resolution Protein Eng, 12, pp. 439 - 446.

Bhattacharya, A. and Curry, S. and Franks, N. (2000) Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures J. Biol. Chem, 275, pp. 38731 - 38738.

Bhattacharya, A. and Grüne, T. and Curry, S. (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin J. Mol. Biol, 303, pp. 721 - 732.

Petitpas, I. and Bhattacharya, A. and Twine, S. and East, M. and Curry, S. (2001) Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I J. Biol. Chem, 276, pp. 22804 - 22809.

Wardell, M. and Wang, Z. and Ho, J. and Robert, J. and Rüker, F. and Ruble, J. and Carter, D. (2002) The atomic structure of human methemalbumin at 1.9 Å Biochem. Biophys. Res. Commun, 291, pp. 813 - 819.

Petitpas, I. and Petersen, C. and Ha, C. and Bhattacharya, A. and Zunszain, P. and Ghuman, J. and Bhagavan, N. and Curry, S. (2003) Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia Proc. Natl. Acad. Sci. USA, 100, pp. 6440 - 6445.

Zunszain, P. and Ghuman, J. and Komatsu, T. and Tsuchida, E. and Curry, S. (2003) Crystal structural analysis of human serum albumin complexed with hemin and fatty acid BMC Struct. Biol, 3, pp. 6.

Sudlow, G. and Birkett, D. and Wade, D. (1976) Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol, 12, pp. 1052 - 1061.

Diana, F. and Veronich, K. and Kapoor, A. (1989) Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin J. Pharm. Sci, 78, pp. 195 - 199.

Yamasaki, K. and Maruyama, T. and Yoshimoto, K. and Tsutsumi, Y. and Narazaki, R. and Fukuhara, A. and Kragh-Hansen, U. and Otagiri, M. (1999) Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition Biochim. Biophys. Acta, 1432, pp. 313 - 323.

Dockal, M. and Chang, M. and Carter, D. and Rüker, F. (2000) Five recombinant fragments of human serum albumin. Tools for the characterization of the warfarin binding site Protein Sci, 9, pp. 1455 - 1465.

Baroni, S. and Mattu, M. and Vannini, A. and Cipollone, R. and Aime, S. and Ascenzi, P. and Fasano, M. (2001) Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study Eur. J. Biochem, 268, pp. 6214 - 6220.

Ghuman, J. and Zunszain, P. and Petitpas, I. and Bhattacharya, A. and Otagiri, M. and Curry, S. (2005) Structural basis of the drug-binding specificity of human serum albumin J. Mol. Biol, 353, pp. 38 - 52.

Hamilton, J. and Cistola, D. and Morrisett, J. and Sparrow, J. and Small, D. (1984) Interactions of myristic acid with bovine serum albumin: a 13C NMR study Proc. Natl. Acad. Sci. USA, 81, pp. 3718 - 3722.

Chuang, V. and Otagiri, M. (2002) How do fatty acids cause allosteric binding of drugs to human serum albumin Pharm. Res, 19, pp. 1458 - 1464.

Hamilton, J. (2004) Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us Prog. Lipid. Res, 43, pp. 177 - 199.

Wilting, J. and van der Giesen, W. and Janssen, L. and Weideman, M. and Otagiri, M. and Perrin, J. (1980) The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis J. Biol. Chem, 255, pp. 3032 - 3037.

Janssen, L. and Van Wilgenburg, M. and Wilting, J. (1981) Human serum albumin as an allosteric two-state protein. Evidence from effects of calcium and warfarin on proton binding behaviour Biochim. Biophys. Acta, 669, pp. 244 - 250.

Dockal, M. and Carter, D. and Rüker, F. (1999) The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties J. Biol. Chem, 274, pp. 29303 - 29310.

Fitos, I. and Visy, J. and Simonyi, M. and Hermansson, J. (1999) Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate Chirality, 11, pp. 115 - 120.

Fasano, M. and Baroni, S. and Vannini, A. and Ascenzi, P. and Aime, S. (2001) Relaxometric characterization of human hemalbumin J. Biol. Inorg. Chem, 6, pp. 650 - 658.

Mattu, M. and Vannini, A. and Coletta, M. and Fasano, M. and Ascenzi, P. (2001) Effect of bezafibrate and clofibrate on the heme-iron geometry of ferrous nitrosylated heme-human serum albumin: an EPR study J. Inorg. Biochem, 84, pp. 293 - 296.

Fitos, I. and Visy, J. and Kardos, J. (2002) Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction Chirality, 14, pp. 442 - 448.

Sakai, T. and Yamasaki, K. and Sako, T. and Kragh-Hansen, U. and Suenaga, A. and Otagiri, M. (2001) Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin Pharm. Res, 18, pp. 520 - 524.

Fasano, M. and Mattu, M. and Coletta, M. and Ascenzi, P. (2002) The heme-iron geometry of ferrous nitrosylated heme-serum lipoproteins, hemopexin, and albumin: a comparative EPR study J. Inorg. Biochem, 91, pp. 487 - 490.

Ascenzi, P. and Bocedi, A. and Notari, S. and Menegatti, E. and Fasano, M. (2005) Heme impairs allosterically drug binding to human serum albumin Sudlow's site I Biochem. Biophys. Res. Commun, 334, pp. 481 - 486.

Wilding, G. and Feldhoff, R. and Vesell, E. (1977) Concentration-dependent effects of fatty acids on warfarin binding to albumin Biochem. Pharmacol, 26, pp. 1143 - 1146.

Rietbrock, N. and Menke, G. and Reuter, G. and Lassmann, A. and Schmeidl, R. (1985) Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies J. Clin. Chem. Clin. Biochem, 23, pp. 719 - 723.

Fanali, G. and Fesce, R. and Agrati, C. and Ascenzi, P. and Fasano, M. (2005) Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin – Optical and NMR spectroscopy characterization FEBS J, 272, pp. 4672 - 4683.

Petersen, C. and Ha, C. and Jameson, D. and Bhagavan, N. (1996) Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia J. Biol. Chem, 271, pp. 19110 - 19117.

Chen, J. and Hage, D. (2004) Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography Nat. Biotechnol, 22, pp. 1445 - 1448.

Chen, J. and Ohnmacht, C. and Hage, D. (2004) Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography J. Chromatogr. B Analyt. Technol. Biomed. Life Sci, 809, pp. 137 - 145.

Kim, H. and Hage, D. (2005) Chromatographic analysis of carbamazepine binding to human serum albumin J. Chromatogr. B Analyt. Technol. Biomed. Life Sci, 816, pp. 57 - 66.

Sampath, V. and Zhao, X. and Caughey, W. (2001) Anesthetic-like interactions of nitric oxide with albumin and hemeproteins. A mechanism for control of protein function J. Biol. Chem, 276, pp. 13635 - 13643.

Chuang, V. and Kragh-Hansen, U. and Otagiri, M. (2002) Pharmaceutical strategies utilizing recombinant human serum albumin Pharm. Res, 19, pp. 569 - 577.

Bocedi, A. and Notari, S. and Narciso, P. and Bolli, A. and Fasano, M. and Ascenzi, P. (2004) Binding of anti-HIV drugs to human serum albumin IUBMB Life, 56, pp. 609 - 614.

Kratochwil, N. and Huber, W. and Muller, F. and Kansy, M. and Gerber, P. (2004) Predicting plasma protein binding of drugs – revisited Curr. Opin. Drug Discov. Devel, 7, pp. 507 - 512.

Wainer, I. (2004) Finding time for allosteric interactions Nat. Biotechnol, 22, pp. 1376 - 1377.

(2001) Magnetic Resonance in Medicine. Berlin : Blackwell Publishing.

Caravan, P. and Ellison, J. and McMurry, T. and Lauffer, R. (1999) Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications Chem Rev, 99, pp. 2293 - 2352.

Aime, S. and Chiaussa, M. and Digilio, G. and Gianolio, E. and Terreno, E. (1999) Contrast agents for magnetic resonance angiographic applications: 1H and 17O NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high biding affinity to human serum albumin J. Biol. Inorg. Chem, 4, pp. 766 - 774.

Aime, S. and Anelli, P. and Botta, M. and Brocchetta, M. and Canton, S. and Fedeli, F. and Gianolio, E. and Terreno, E. (2002) Relaxometric Evaluation of novel Mn(II) complexes for application as contrast agents in magnetic resonance imaging J. Biol. Inorg. Chem, 7, pp. 58 - 67.

Tóth, E. and Connac, F. and Helm, L. and Adzamli, K. and Merbach, A. (1998) Direct assessment of water exchange on a Gd(III) chelate bound to a protein J. Biol. Inorg. Chem, 3, pp. 606 - 613.

Caravan, P. and Cloutier, N. and Greenfield, M. and McDermid, S. and Dunham, S. and Bulte, J. and Amedio, J., Jr. and Looby, R. and Supkowski, R. and Horrocks, W., Jr. and McMurry, T. and Lauffer, R. (2002) The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates J. Am. Chem. Soc, 124, pp. 3152 - 3162.

Troughton, J. and Greenfield, M. and Greenwood, J. and Dumas, S. and Wiethoff, A. and Wang, J and Spiller, M. and Mc Murry, T. and Caravan, P. (2004) Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent Inorg. Chem, 43, pp. 6313 - 6323.

Caravan, P. and Greenfield, M. and Li, X. and Sherry A., D. (2001) The Gd3+ complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities Inorg. Chem, 40, pp. 6580 - 6587.

Aime, S. and Gianolio, E. and Longo, D. and Pagliarin, R. and Lovazzano, C. and Sisti, M. (2005) New insights for pursuing high relaxivity MRI agents from modelling the binding interaction of GdIII chelates to HSA Chem. Bio. Chem, 6, pp. 818 - 820.

Kragh-Hansen, U. and Pedersen, A. and Galliano, M. and Minchiotti, L. and Brennan, S. and Tarnoky, A. and Franco, M. and Salzano, F. (1996) High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin Biochem. J, 320, pp. 911 - 916.

Nielsen, H. and Kragh-Hansen, U. and Minchiotti, L. and Galliano, M. and Brennan, S. and Tarnoky, A. and Franco, M. and Salzano, F. and Sugita, O. (1997) Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin Biochim. Biophys. Acta, 1342, pp. 191 - 204.

Petersen, C. and Scottolini, A. and Cody, L. and Mandel, M. and Reimer, N. and Bhagavan, N. (1994) A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinemia J. Med. Genet, 31, pp. 355 - 359.

Sunthornthepvarakul, T. and Likitmaskul, S. and Ngowngarmratana, S. (1998) Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect J. Clin. Endocrinol. Metab, 83, pp. 1448 - 1454.

Schnitzer, E. and Pinchuk, I. and Bor, A. and Fairanu, M. and Lichtenberg, D. (1997) The effect of albumin on copper-induced LDL oxidation Biochim. Biophys. Acta, 1344, pp. 300 - 311.

Kragh-Hansen, U. and Brennan, S. and Galliano, M. and Sugita, O. (1989) Binding of warfarin, salicylate and diazepam to genetic variants of human serum albumin with known mutations Mol. Pharmacol, 37, pp. 238 - 242.

Galliano, M. and Watkins, S. and Madison, J. and Putnam, F. and Kragh-Hansen, U. and Cesati, R. and Minchiotti, L. (1998) Structural characterization of three genetic variants of human serum albumin modified in subdomains IIB and IIIA Eur. J. Biochem, 251, pp. 329 - 334.

Minchiotti, L. and Kragh-Hansen, U. and Nielsen, H. and Hardy, E. and Mercier, A. and Galliano, M. (1999) Structural characterization, stability and fatty acid- binding properties of two french variants of human serum albumin Biochim. Biophys. Acta, 1431, pp. 223 - 231.

Campagnoli, M. and Kragh-Hansen, U. and Overgaard, A. and Amoresano, A. and Lyon, A. and Cesati, R. and Sala, A. and Romano, A. and Galliano, M. and Minchiotti, L. (2003) Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin Clin. Biochem, 36, pp. 597 - 605.

Kragh-Hansen, U. and Campagnoli, M. and Dodig, S. and Nielsen, H. and Benko, B. and Raos, M. and Cesati, R. and Sala, A. and Galliano, M. and Minchiotti, L. (2004) Structural analysis and fatty acid-binding properties of two croatian variants of human serum albumin Clin. Chim. Acta, 349, pp. 105 - 111.

Kragh-Hansen, U. and Saito, S. and Nishi, K. and Anraku, M. and Otagiri, M. (2004) Effect of genetic variation on the thermal stability of human serum albumin Biochim. Biophys. Acta, 1747, pp. 81 - 88.

Scholar Hub - Công cụ hỗ trợ trích dẫn và phân tích khoa học Việt Nam

Về chúng tôi

Scholar Hub là công cụ hỗ trợ trích dẫn và phân tích các bài báo, công bố khoa học Việt Nam. Công cụ trợ giúp người nghiên cứu, tạp chí, đơn vị nghiên cứu tra cứu, phân tích và thống kê dữ liệu nghiên cứu khoa học tại Việt Nam và quốc tế.
ScholarHub KHÔNG đăng thông tin tổng hợp, KHÔNG đăng lại nội dung từ các trang báo chí Việt Nam hoặc trang thông tin điện tử khác tại Việt Nam.

Thông tin, cập nhật

Đăng ký Tạp chí tham gia vào Scholar Hub

Phản hồi ý kiến về Scholar Hub

Bài viết, nội dung cập nhật

Chủ đề khoa học

Website liên kết

Phần mềm kiểm tra trùng lặp Kiểm Tra Tài Liệu

Phần mềm xuất bản tạp chí điện tử VOJS

Công cụ kiểm tra chính tả và thể thức Viver

Nền tảng trắc nghiệm và đề thi đa lĩnh vực LetQA